134 related articles for article (PubMed ID: 9177872)
1. Bone turnover in neonates: changes of urinary excretion rate of collagen type I cross-linked peptides during the first days of life and influence of gestational age.
Mora S; Prinster C; Bellini A; Weber G; Proverbio MC; Puzzovio M; Bianchi C; Chiumello G
Bone; 1997 Jun; 20(6):563-6. PubMed ID: 9177872
[TBL] [Abstract][Full Text] [Related]
2. Urinary excretion of cross-linked N-telopeptides of type 1 collagen to assess bone resorption in infants from birth to 1 year of age.
Lapillonne A; Travers R; DiMaio M; Salle BL; Glorieux FH
Pediatrics; 2002 Jul; 110(1 Pt 1):105-9. PubMed ID: 12093954
[TBL] [Abstract][Full Text] [Related]
3. [Normal urine levels of the aminoterminal telopeptide of type I collagen (NTx) in premature newborns in the first week of life].
Praticò G; Palano GM; Curreri R; Marletta M; Parisi G; Praticò ER
Pediatr Med Chir; 2005; 27(1-2):81-5. PubMed ID: 16922049
[TBL] [Abstract][Full Text] [Related]
4. Urinary excretion of type I collagen crosslinked N-telopeptides in healthy Japanese adults: age- and sex-related changes and reference limits.
Sone T; Miyake M; Takeda N; Fukunaga M
Bone; 1995 Oct; 17(4):335-9. PubMed ID: 8573404
[TBL] [Abstract][Full Text] [Related]
5. Specificity of urinary excretion of cross-linked N-telopeptides of type I collagen as a marker of bone turnover.
Rosen HN; Dresner-Pollak R; Moses AC; Rosenblatt M; Zeind AJ; Clemens JD; Greenspan SL
Calcif Tissue Int; 1994 Jan; 54(1):26-9. PubMed ID: 8118749
[TBL] [Abstract][Full Text] [Related]
6. Changes in urinary excretion of type-I collagen cross-linked C-telopeptide and N-telopeptide in perimenopausal women.
Taga M; Shirashu K; Minaguchi H
Horm Res; 1998; 49(2):86-90. PubMed ID: 9485177
[TBL] [Abstract][Full Text] [Related]
7. [Normal urinary levels of telopeptide aminoterminal (NTx) of type I collagen in healthy term newborns and infants in the first month of life].
Praticò G; Palano GM; Curreri R; D'Agata A; Carpinato C; Sottile F; Sorge A
Pediatr Med Chir; 2002; 24(3):213-6. PubMed ID: 12236035
[TBL] [Abstract][Full Text] [Related]
8. The measurement of urinary amino-terminal telopeptides of type I collagen to monitor bone resorption in patients with primary hyperparathyroidism.
Minisola S; Pacitti MT; Rosso R; Pellegrino C; Ombricolo E; Pisani D; Romagnoli E; Damiani C; Aliberti G; Scarda A; Mazzuoli SF
J Endocrinol Invest; 1997 Oct; 20(9):559-65. PubMed ID: 9413811
[TBL] [Abstract][Full Text] [Related]
9. Longitudinal evaluation of a bone resorption marker in elderly subjects.
Bollen AM; Kiyak HA; Eyre DR
Osteoporos Int; 1997; 7(6):544-9. PubMed ID: 9604050
[TBL] [Abstract][Full Text] [Related]
10. Application of a new serum assay for type I collagen cross-linked N-telopeptides: assessment of diurnal changes in bone turnover with and without alendronate treatment.
Gertz BJ; Clemens JD; Holland SD; Yuan W; Greenspan S
Calcif Tissue Int; 1998 Aug; 63(2):102-6. PubMed ID: 9685512
[TBL] [Abstract][Full Text] [Related]
11. The effect of hormone replacement therapy in postmenopausal women on urinary C-telopeptide and N-telopeptide of type I collagen, new markers of bone resorption.
Taga M; Uemura T; Minaguchi H
J Endocrinol Invest; 1998 Mar; 21(3):154-9. PubMed ID: 9591210
[TBL] [Abstract][Full Text] [Related]
12. Urinary N-telopeptides of type I collagen in healthy children.
Sato J; Hasegawa K; Tanaka H; Morishima T
Pediatr Int; 2010 Jun; 52(3):398-401. PubMed ID: 20113422
[TBL] [Abstract][Full Text] [Related]
13. Change of cross-linked telopeptide of type I collagen (ICTP) and other bone resorption markers in patients with bone fragility fractures.
Takahara K; Kamimura M; Hashidate H; Uchiyama S; Nakagawa H
J Orthop Sci; 2007 May; 12(3):219-26. PubMed ID: 17530373
[TBL] [Abstract][Full Text] [Related]
14. Measurement of urinary excretion of nonisomerized and beta-isomerized forms of type I collagen breakdown products to monitor the effects of the bisphosphonate zoledronate in Paget's disease.
Garnero P; Gineyts E; Schaffer AV; Seaman J; Delmas PD
Arthritis Rheum; 1998 Feb; 41(2):354-60. PubMed ID: 9485094
[TBL] [Abstract][Full Text] [Related]
15. Effects of gestational age, maternal diabetes, and intrauterine growth retardation on markers of fetal bone turnover in amniotic fluid.
Harrast SD; Kalkwarf HJ
Calcif Tissue Int; 1998 Mar; 62(3):205-8. PubMed ID: 9501952
[TBL] [Abstract][Full Text] [Related]
16. A prospective longitudinal study of urinary excretion of a bone resorption marker in adolescents.
Bollen AM
Ann Hum Biol; 2000; 27(2):199-211. PubMed ID: 10768424
[TBL] [Abstract][Full Text] [Related]
17. Changes in urinary excretions of C-telopeptide and cross-linked N-telopeptide of type I collagen during pregnancy and puerperium.
Yamaga A; Taga M; Minaguchi H
Endocr J; 1997 Oct; 44(5):733-8. PubMed ID: 9466331
[TBL] [Abstract][Full Text] [Related]
18. Dose-response relationships between energy availability and bone turnover in young exercising women.
Ihle R; Loucks AB
J Bone Miner Res; 2004 Aug; 19(8):1231-40. PubMed ID: 15231009
[TBL] [Abstract][Full Text] [Related]
19. Specific changes of urinary excretion of cross-linked N-telopeptides of type I collagen in pre- and postmenopausal women: correlation with other markers of bone turnover.
Gorai I; Taguchi Y; Chaki O; Nakayama M; Minaguchi H
Calcif Tissue Int; 1997 Apr; 60(4):317-22. PubMed ID: 9075625
[TBL] [Abstract][Full Text] [Related]
20. Urinary excretion of type I collagen cross-linked N-telopeptide and serum bone-specific alkaline phosphatase analysis to determine the correlation of age and back-pain related changes in elderly women.
Kamimura M; Uchiyama S; Takahara K; Hashidate H; Kawaguchi A; Nakagawa H
J Bone Miner Metab; 2005; 23(6):495-500. PubMed ID: 16261458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
